How big is the digital biomarkers market | Insights & Growth 2025

Q: What is the market size of the Digital Biomarkers market in 2025 and 2031?

The Digital Biomarkers market was expected to be valued at approximately USD 2.4 billion in 2025 and projected to reach around USD 3.85 billion by 2031.

Q: What is the CAGR of the Digital Biomarkers market between 2025 and 2031?

The Digital Biomarkers market is anticipated to grow at a CAGR of 17.50% during the forecast period.

Q: What are the key trends in the Digital Biomarkers market?

Key trends include increased adoption of wearable tech, AI-driven health monitoring, use of mobile platforms in clinical trials, and regulatory support for digital health tools.

Q: What are the main drivers of the Digital Biomarkers market?

The Digital Biomarkers market is driven by demand for remote monitoring, chronic disease management, rising tech integration in healthcare, and growth in personalized medicine.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA6052

Publication Date: Jul 2025

What is the digital biomarkers Market Size?

According to 6Wresearch internal database and industry insights, Global digital biomarkers market was valued atUSD 2.4 billion in 2024 and is anticipated to exceedUSD3.85 billion by 2031, registering a steady at aCAGR of 17.50% during the forecast period.

View Main Report

Schedule Analyst Call

This growth is fueled by the increasing integration of digital health technologies, rising prevalence of chronic diseases, and growing need for real-time patient monitoring and personalized healthcare. The adoption of wearable devices, mobile apps, and advanced analytics is accelerating the demand for digital biomarkers across clinical trials, diagnostics, and therapeutic monitoring. Furthermore, rising R&D investments and regulatory advancements are reinforcing market expansion.

Major Growth Factors of the Digital Biomarkers Market

Rising adoption of wearable health devices and mobile apps
Increasing demand for real-time health monitoring
Technological advancements in AI and machine learning
Growing prevalence of chronic and lifestyle diseases
Rising R&D investment in personalized medicine
Expansion of remote patient monitoring solutions
Regulatory push towards digital health integration
Enhanced interest from pharmaceutical companies for clinical trials

Digital Biomarkers Market Trends

The Digital Biomarkers market is witnessing strong momentum due to a shift toward connected healthcare and data-driven diagnostics. There is a notable surge in demand for non-invasive monitoring solutions, integration of AI for predictive analytics, and the use of biosensors and smartwatches in chronic disease management. Clinical trials are increasingly leveraging digital biomarkers to streamline patient data collection and enhance trial accuracy.

Emerging Developments in the Digital Biomarkers Market

The Digital Biomarkers market is emerging through new partnerships between tech firms and healthcare providers, innovative mobile health platforms, and breakthroughs in sensor technology. Regulatory bodies are showing increased acceptance of digital endpoints, supporting faster adoption. Additionally, growing investments from pharmaceutical and biotech companies are catalyzing the integration of digital biomarkers into drug development pipelines.